HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-05-10
著者
-
Hayashi Shin-ichi
Division Of Endocrinology Saitama Cancer Center Research Institute
-
Tanaka Yukie
Division Of Pediatrics Department Of Homeostatic Regulation And Development Niigata University Gradu
-
Nakatsura Tetsuya
Section For Cancer Immunotherapy Investigative Treatment Division
-
Shirakawa Hirofumi
Section For Cancer Immunotherapy Investigative Treatment Division
-
Hayashi Shin-ichi
Division Of Immunology Department Of Molecular And Cellular Biology School Of Life Science Faculty O
-
Suzuki Shiro
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Yoshikawa Toshiaki
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Nakatsugawa Munehide
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
NOBUOKA Daisuke
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative O
-
SAKEMURA Noriko
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative O
-
MOTOMURA Yutaka
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative O
-
Shirakawa Hirofumi
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Tanaka Yukie
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Nobuoka Daisuke
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Motomura Yutaka
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Nakatsura Tetsuya
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
-
Sakemura Noriko
Section For Cancer Immunotherapy Investigative Treatment Division Research Center For Innovative Onc
関連論文
- Usefulness of GPT for Diagnosis of Metabolic Syndrome in Obese Japanese Children
- Clinical Impact of Assay of Estrogen Receptor βcx in Breast Cancer
- Lower Birth Weight Associated with Current Overweight Status Is Related with the Metabolic Syndrome in Obese Japanese Children
- Usefulness of Serum Adiponectin Level as a Diagnostic Marker of Metabolic Syndrome in Obese Japanese Children
- Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes
- Distinct antigen trafficking from skin in the steady and active states
- Isolation and characterization of Kit-independent melanocyte precursors induced in the skin of Steel factor transgenic mice
- Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
- Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients
- A Study of Estrogen Signaling Using DNA Microarray in Human Breast Cancer
- Contribution of Neural Crest Cells in Tooth Development and the Possibility of Tooth Regeneration
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- Presence and distribution of neural crest-derived cells in the murine developing thymus and their potential for differentiation
- Histological prognostic parameters for adenocarcinoma of the pancreatic head. Proposal for a scoring system for prediction of outcome
- Silencing of secreted protein acidic and rich in cysteine inhibits the growth of human melanoma cells with G_1 arrest induction
- HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells
- Compliance with and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy
- Compliance with and effects of preoperative immunonutrition in patients undergoing pancreaticoduodenectomy
- Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma